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ABSTRACT:
 A two-month-old male infant presented with history of respiratory difficulty and got admitted with provisional 
diagnosis of pneumonia. On examination patient was having unilateral nasal hypoplasia and cyanosis with 
echocardiography showing truncus arteriosus. Detail history revealed that mother had valve replacement and she 
was taking warfarin during pregnancy. After initial management patient was referred to pediatric cardiac surgery 
and plastic surgery for further management. Parents were counseled regarding contraception and family planning.   
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Fetal warfarin syndrome (FWS), Di Sala syndrome 
or warfarin embryopathy is one of the rare fetal 
anomalies due to exposure of fetus to warfarin in 
utero.1 Warfarin is a teratogenic drug that causes 
fetal anomaly especially in the first trimester and 
associated with fetal loss.2 Embryopathy due to 
warfarin is characterized by the abnormalities of 
cartilages and bones known as chondrodysplasia 
punctata. Babies who are affected may have nasal 
hypoplasia, cardiac anomalies, microphthalmia, 
excessive calcifications in the epiphyses and 
vertebrae, hypoplasia of the extremities, intrauterine 
growth retardation, scoliosis, deafness, and mental 
retardation.3 Risk of teratogenicity is not predictable 
with any dose of warfarin. In women who have 
mechanical valves and receiving warfarin, the 
optimal dose is not defined.4 We are reporting case 
of one two months old male child, diagnosed as case 
of FWS. After initial management patient was 
referred to pediatric cardiac surgery and pediatric 




A two-month-old male infant presented to pediatric 
emergency department of Ayub Teaching Hospital, 
Abbottabad with history of respiratory difficulty. 
Patient was admitted in pediatric department with 
provisional diagnosis of pneumonia. On clinical 
examination patient was having nasal hypoplasia 
and cyanosis. There was systolic murmur on cardiac 
auscultation. Echocardiography showed large 
membranous ventricular defect and truncus 
arteriosus. On detail medical history mother 
informed that she had cardiac surgery for sever 
mitral stenosis and prostatic cardiac valve was 
placed in heart. She has been taking warfarin for last 
three years. This pregnancy was spontaneous, and 
she only visited local doctor working as obstetrician 
during pregnancy in last trimester. Neither doctor 
inquired nor she informed about her warfarin intake. 
Baby was delivered via spontaneous vaginal 
delivery at local clinic. After birth of baby, patient 
was having recurrent acute respiratory infection as 
mother visited local doctor multiple times, but 
cardiac disease could not be suspected or diagnosed. 
Then patient got too sick to be taken to tertiary care 
hospital. After stabilization of patient condition 
patient was referred to pediatric cardiac surgery and 
pediatric plastic surgery for further management. 
Parents were counseled regarding contraception and 
family planning. Proper consent was taken from 
parents for presenting this case report. 
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Figure 1: Patient CXR 
 
 








In developing countries including Pakistan, 
rheumatic heart disease is one of the major causes of 
cardiac illness in childbearing women.5 Cardiac 
diseases are there in 1-3% of pregnant women.6 
Warfarin is one drug of choice for the women with 
valve replacement due to RHD but there is risk of 
fetal malformation and abortion.3 Di Sala in 1966, 
reported one neonate born to mother having mitral 
valve prosthesis and she was taking warfarin during 
first trimester of pregnancy. Baby had clinical 
features of nasal structure hypoplasia, bilateral optic 
atrophy and blindness, and later on mental 
retardation. Then Holmes et al mentioned same 
infant and illustrated as a warfarin embryopathy.7 In 
our case mother kept on taking warfarin during first 
trimester of pregnancy and baby had nasal 
hypoplasia and cardiac anomaly. Warfarin also 
causes chondrodysplasia punctata, which is 
abnormal calcification in the cartilage of developing 
bones.8 But x-ray long bones in our patient did not 
reveal the finding of chondrodysplasia punctata. 
Unfractionated heparin or low molecular weight 
heparin are used especially during first trimester of 
pregnancy instead of oral anticoagulants as still there 
is no consensus on use of anticoagulants in 
pregnancy.9,10 In our case, the pregnancy was 
spontaneous. Mother also did not visit during the 
first trimester of pregnancy and after delivery there 
was no referral for baby by the doctor despite having 
nasal hypoplasia. There should be standard protocols 
implemented including family planning and 
contraception for mothers with reproductive age 
who are started on teratogenic drugs.11 The purpose 
of this case report is to emphasize that warfarin 
exposure during pregnancy especially during the 
first trimester can lead to fetal defects and congenital 
anomalies. Proper history and counselling should be 
part of management of mothers having RHD and 
valve replacement taking oral anticoagulants. 
 
CONCLUSION:  
It was concluded that warfarin causes fetal defects 
and congenital anomalies as in this case the child 
had unilateral nasal hypoplasia and cyanosis with 
echocardiography showing truncus arteriosus 
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